Gary Lu

2.0k total citations
62 papers, 1.3k citations indexed

About

Gary Lu is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Gary Lu has authored 62 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Hematology, 24 papers in Genetics and 16 papers in Pathology and Forensic Medicine. Recurrent topics in Gary Lu's work include Acute Myeloid Leukemia Research (26 papers), Chronic Lymphocytic Leukemia Research (15 papers) and Chronic Myeloid Leukemia Treatments (15 papers). Gary Lu is often cited by papers focused on Acute Myeloid Leukemia Research (26 papers), Chronic Lymphocytic Leukemia Research (15 papers) and Chronic Myeloid Leukemia Treatments (15 papers). Gary Lu collaborates with scholars based in United States, China and Australia. Gary Lu's co-authors include L. Jeffrey Medeiros, Chung S. Yang, Carlos E. Bueso‐Ramos, C. Cameron Yin, Hang Xiao, Jie Liao, Huanyu Jin, Guang‐Yu Yang, David Reisman and Yu‐Kuo Chen and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Gary Lu

62 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gary Lu United States 19 420 394 379 263 255 62 1.3k
Elisabeth Koller Austria 23 481 1.1× 108 0.3× 720 1.9× 257 1.0× 185 0.7× 75 1.7k
Güray Saydam Türkiye 22 533 1.3× 119 0.3× 678 1.8× 278 1.1× 515 2.0× 160 1.6k
Alice H. Wang United States 23 338 0.8× 516 1.3× 61 0.2× 659 2.5× 158 0.6× 43 1.5k
Stefano Manarini Italy 22 485 1.2× 97 0.2× 679 1.8× 179 0.7× 315 1.2× 36 2.1k
Junmin Zhou United States 19 539 1.3× 206 0.5× 187 0.5× 447 1.7× 87 0.3× 55 1.5k
Mark Hong Lee South Korea 13 383 0.9× 132 0.3× 197 0.5× 245 0.9× 82 0.3× 63 904
Jianlin Qiao China 20 612 1.5× 89 0.2× 508 1.3× 402 1.5× 121 0.5× 108 1.6k
W. Heller Germany 15 349 0.8× 148 0.4× 227 0.6× 389 1.5× 124 0.5× 81 1.5k
Dapeng Wu China 24 903 2.1× 126 0.3× 252 0.7× 481 1.8× 85 0.3× 88 1.8k
Stanley J. Hollenbach United States 20 469 1.1× 90 0.2× 558 1.5× 211 0.8× 347 1.4× 40 2.0k

Countries citing papers authored by Gary Lu

Since Specialization
Citations

This map shows the geographic impact of Gary Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Lu more than expected).

Fields of papers citing papers by Gary Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Lu. The network helps show where Gary Lu may publish in the future.

Co-authorship network of co-authors of Gary Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Gary Lu. A scholar is included among the top collaborators of Gary Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary Lu. Gary Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gao, Jinyu, Chaochao Luo, Junxiao Zhang, et al.. (2024). Impact of genomic and epigenomic alterations of multigene on a multicancer pedigree. Cancer Medicine. 13(13). e7394–e7394. 1 indexed citations
2.
Agarwala, Sanjiv S., Merrick I. Ross, Jonathan S. Zager, et al.. (2020). 1125P A phase Ib study of rose bengal disodium and anti-PD-1 in metastatic cutaneous melanoma: Results in patients naïve to immune checkpoint blockade. Annals of Oncology. 31. S756–S756. 3 indexed citations
3.
Zager, Jonathan S., Amod Sarnaik, Shari Pilon‐Thomas, et al.. (2020). 1123P A phase Ib study of rose bengal disodium and anti-PD-1 in metastatic cutaneous melanoma: Initial results in patients refractory to checkpoint blockade. Annals of Oncology. 31. S755–S756. 4 indexed citations
4.
Shervani, Saira, et al.. (2018). Prognostic factors and hazard ratios in colorectal cancer patients over 80 years of age: a retrospective, 20-year, single institution review. Journal of Gastrointestinal Oncology. 9(2). 254–262. 4 indexed citations
5.
Lu, Gary, et al.. (2016). Successful Treatment of Pegaspargase-Induced Acute Hepatotoxicity with Vitamin B Complex and L-Carnitine. Baylor University Medical Center Proceedings. 29(1). 46–47. 15 indexed citations
6.
Ai, Di, et al.. (2015). Extramedullary blast crisis as initial presentation in chronic myeloid leukemia with the e1a2 BCR-ABL1 transcript: A case report. Molecular and Clinical Oncology. 3(6). 1319–1322. 2 indexed citations
7.
Pham, Lan V., Gary Lu, Archito T. Tamayo, et al.. (2015). Establishment and characterization of a novel MYC/BCL2 “double-hit” diffuse large B cell lymphoma cell line, RC. Journal of Hematology & Oncology. 8(1). 121–121. 9 indexed citations
8.
Yin, C. Cameron, Guilin Tang, Gary Lu, et al.. (2015). Del(20q) in patients with chronic lymphocytic leukemia: a therapy-related abnormality involving lymphoid or myeloid cells. Modern Pathology. 28(8). 1130–1137. 6 indexed citations
9.
Hamdi, Amir, Aimaz Afrough, Tariq Muzzafar, et al.. (2014). Donor Cell–Derived Myelodysplastic Syndrome With Ring Chromosome 7 After Allogeneic Hematopoietic Stem Cell Transplant in 2 Patients With Lymphomas as Primary Disease. Clinical Lymphoma Myeloma & Leukemia. 14(5). e151–e155. 2 indexed citations
10.
11.
You, M. James, Ken H. Young, Pei Lin, et al.. (2012). Advances in the molecular pathobiology of B-lymphoblastic leukemia. Human Pathology. 43(9). 1347–1362. 44 indexed citations
12.
Konoplev, Sergej, C. Cameron Yin, Steven M. Kornblau, et al.. (2012). Molecular characterization ofde novoPhiladelphia chromosome-positive acute myeloid leukemia. Leukemia & lymphoma. 54(1). 138–144. 70 indexed citations
13.
Kanagal‐Shamanna, Rashmi, L. Jeffrey Medeiros, Gary Lu, et al.. (2012). High‐grade B cell lymphoma, unclassifiable, with blastoid features: an unusual morphological subgroup associated frequently with BCL2 and/or MYC gene rearrangements and a poor prognosis. Histopathology. 61(5). 945–954. 37 indexed citations
14.
Kanagal‐Shamanna, Rashmi, Carlos E. Bueso‐Ramos, Bedia A. Barkoh, et al.. (2011). Myeloid neoplasms with isolated isochromosome 17q represent a clinicopathologic entity associated with myelodysplastic/myeloproliferative features, a high risk of leukemic transformation, and wild‐type TP53. Cancer. 118(11). 2879–2888. 49 indexed citations
15.
Wang, S. A., Kausar J. Jabbar, Gary Lu, et al.. (2010). Trisomy 11 in myelodysplastic syndromes defines a unique group of disease with aggressive clinicopathologic features. Leukemia. 24(4). 740–747. 12 indexed citations
16.
Lu, Gary, et al.. (2009). Complex 3D velocity‐depth model with RTM from top‐to‐down. 3685–3689. 2 indexed citations
17.
Yin, C. Cameron, Lynne V. Abruzzo, Xiaoyan Qiu, et al.. (2009). del(15q) is a recurrent minor-route cytogenetic abnormality in the clonal evolution of chronic myelogenous leukemia. Cancer Genetics and Cytogenetics. 192(1). 18–23. 5 indexed citations
18.
Liao, Jie, Darren N. Seril, Gary Lu, et al.. (2008). Increased susceptibility of chronic ulcerative colitis‐induced carcinoma development in DNA repair enzyme Ogg1 deficient mice. Molecular Carcinogenesis. 47(8). 638–646. 47 indexed citations
19.
Lu, Gary, C. Cameron Yin, L. Jeffrey Medeiros, & Lynne V. Abruzzo. (2008). Deletion 15q as the sole abnormality in acute myeloid leukemia: report of three cases and review of the literature. Cancer Genetics and Cytogenetics. 188(2). 118–123. 2 indexed citations
20.
Reisman, David, et al.. (2003). Loss of heterozygosity and p53 expression in Pterygium. Cancer Letters. 206(1). 77–83. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elisabeth Koller Breakdown of academic impact, for papers by Güray Saydam Breakdown of academic impact, for papers by Alice H. Wang Breakdown of academic impact, for papers by Stefano Manarini Breakdown of academic impact, for papers by Junmin Zhou Breakdown of academic impact, for papers by Mark Hong Lee Breakdown of academic impact, for papers by Jianlin Qiao Breakdown of academic impact, for papers by W. Heller Breakdown of academic impact, for papers by Dapeng Wu Breakdown of academic impact, for papers by Stanley J. Hollenbach
Rankless by CCL
2026